Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
35,033
archived clinical trials in
Lung Cancer

Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared With Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Advanced Non-small Cell Lung Cancer.
Status: Enrolling
Updated:  4/9/2018
Facey Medical Foundation
mi
from
Mission Hills, CA
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared With Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Advanced Non-small Cell Lung Cancer.
Status: Enrolling
Updated: 4/9/2018
Facey Medical Foundation
mi
from
Mission Hills, CA
Click here to add this to my saved trials
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared With Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Advanced Non-small Cell Lung Cancer.
Status: Enrolling
Updated:  4/9/2018
Eastern CT Hematology Oncology
mi
from
Norwich, CT
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared With Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Advanced Non-small Cell Lung Cancer.
Status: Enrolling
Updated: 4/9/2018
Eastern CT Hematology Oncology
mi
from
Norwich, CT
Click here to add this to my saved trials
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared With Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Advanced Non-small Cell Lung Cancer.
Status: Enrolling
Updated:  4/9/2018
Christiana Care Health Services, Inc
mi
from
Newark, DE
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared With Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Advanced Non-small Cell Lung Cancer.
Status: Enrolling
Updated: 4/9/2018
Christiana Care Health Services, Inc
mi
from
Newark, DE
Click here to add this to my saved trials
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared With Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Advanced Non-small Cell Lung Cancer.
Status: Enrolling
Updated:  4/9/2018
Swedish Covenant Hospital
mi
from
Chicago, IL
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared With Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Advanced Non-small Cell Lung Cancer.
Status: Enrolling
Updated: 4/9/2018
Swedish Covenant Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared With Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Advanced Non-small Cell Lung Cancer.
Status: Enrolling
Updated:  4/9/2018
Cotton-O'Neil Clinical Research Center
mi
from
Topeka, KA
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared With Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Advanced Non-small Cell Lung Cancer.
Status: Enrolling
Updated: 4/9/2018
Cotton-O'Neil Clinical Research Center
mi
from
Topeka, KA
Click here to add this to my saved trials
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared With Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Advanced Non-small Cell Lung Cancer.
Status: Enrolling
Updated:  4/9/2018
Norton Healthcare
mi
from
Louisville, KY
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared With Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Advanced Non-small Cell Lung Cancer.
Status: Enrolling
Updated: 4/9/2018
Norton Healthcare
mi
from
Louisville, KY
Click here to add this to my saved trials
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared With Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Advanced Non-small Cell Lung Cancer.
Status: Enrolling
Updated:  4/9/2018
Christus Cancer Treatment Center
mi
from
Shreveport, LA
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared With Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Advanced Non-small Cell Lung Cancer.
Status: Enrolling
Updated: 4/9/2018
Christus Cancer Treatment Center
mi
from
Shreveport, LA
Click here to add this to my saved trials
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared With Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Advanced Non-small Cell Lung Cancer.
Status: Enrolling
Updated:  4/9/2018
Henry Ford Allegiance Health
mi
from
Jackson, MI
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared With Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Advanced Non-small Cell Lung Cancer.
Status: Enrolling
Updated: 4/9/2018
Henry Ford Allegiance Health
mi
from
Jackson, MI
Click here to add this to my saved trials
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared With Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Advanced Non-small Cell Lung Cancer.
Status: Enrolling
Updated:  4/9/2018
Park Nicolett
mi
from
Saint Louis Park, MN
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared With Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Advanced Non-small Cell Lung Cancer.
Status: Enrolling
Updated: 4/9/2018
Park Nicolett
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared With Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Advanced Non-small Cell Lung Cancer.
Status: Enrolling
Updated:  4/9/2018
Boone Hospital Center
mi
from
Columbia, MO
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared With Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Advanced Non-small Cell Lung Cancer.
Status: Enrolling
Updated: 4/9/2018
Boone Hospital Center
mi
from
Columbia, MO
Click here to add this to my saved trials
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared With Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Advanced Non-small Cell Lung Cancer.
Status: Enrolling
Updated:  4/9/2018
Washington University in St. Louis
mi
from
Saint Louis, MO
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared With Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Advanced Non-small Cell Lung Cancer.
Status: Enrolling
Updated: 4/9/2018
Washington University in St. Louis
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared With Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Advanced Non-small Cell Lung Cancer.
Status: Enrolling
Updated:  4/9/2018
Nebraska Methodist Hospital
mi
from
Omaha, NE
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared With Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Advanced Non-small Cell Lung Cancer.
Status: Enrolling
Updated: 4/9/2018
Nebraska Methodist Hospital
mi
from
Omaha, NE
Click here to add this to my saved trials
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared With Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Advanced Non-small Cell Lung Cancer.
Status: Enrolling
Updated:  4/9/2018
Northern Westchester Hospital Association
mi
from
Mount Kisco, NY
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared With Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Advanced Non-small Cell Lung Cancer.
Status: Enrolling
Updated: 4/9/2018
Northern Westchester Hospital Association
mi
from
Mount Kisco, NY
Click here to add this to my saved trials
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared With Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Advanced Non-small Cell Lung Cancer.
Status: Enrolling
Updated:  4/9/2018
East Carolina University
mi
from
Greenville, NC
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared With Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Advanced Non-small Cell Lung Cancer.
Status: Enrolling
Updated: 4/9/2018
East Carolina University
mi
from
Greenville, NC
Click here to add this to my saved trials
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared With Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Advanced Non-small Cell Lung Cancer.
Status: Enrolling
Updated:  4/9/2018
Levine Cancer Center
mi
from
Mint Hill, NC
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared With Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Advanced Non-small Cell Lung Cancer.
Status: Enrolling
Updated: 4/9/2018
Levine Cancer Center
mi
from
Mint Hill, NC
Click here to add this to my saved trials
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared With Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Advanced Non-small Cell Lung Cancer.
Status: Enrolling
Updated:  4/9/2018
Pinehurst Medical Clinic
mi
from
Pinehurst, NC
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared With Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Advanced Non-small Cell Lung Cancer.
Status: Enrolling
Updated: 4/9/2018
Pinehurst Medical Clinic
mi
from
Pinehurst, NC
Click here to add this to my saved trials
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared With Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Advanced Non-small Cell Lung Cancer.
Status: Enrolling
Updated:  4/9/2018
Providence Health & Services
mi
from
Portland, OR
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared With Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Advanced Non-small Cell Lung Cancer.
Status: Enrolling
Updated: 4/9/2018
Providence Health & Services
mi
from
Portland, OR
Click here to add this to my saved trials
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared With Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Advanced Non-small Cell Lung Cancer.
Status: Enrolling
Updated:  4/9/2018
Hope Cancer Center of East Texas (Tyler Hem Onc)
mi
from
Tyler, TX
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared With Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Advanced Non-small Cell Lung Cancer.
Status: Enrolling
Updated: 4/9/2018
Hope Cancer Center of East Texas (Tyler Hem Onc)
mi
from
Tyler, TX
Click here to add this to my saved trials
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared With Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Advanced Non-small Cell Lung Cancer.
Status: Enrolling
Updated:  4/9/2018
Virginia Cancer Institute
mi
from
Richmond, VA
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared With Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Advanced Non-small Cell Lung Cancer.
Status: Enrolling
Updated: 4/9/2018
Virginia Cancer Institute
mi
from
Richmond, VA
Click here to add this to my saved trials
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared With Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Advanced Non-small Cell Lung Cancer.
Status: Enrolling
Updated:  4/9/2018
University of Washington (Swedish General)
mi
from
Seattle, WA
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared With Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Advanced Non-small Cell Lung Cancer.
Status: Enrolling
Updated: 4/9/2018
University of Washington (Swedish General)
mi
from
Seattle, WA
Click here to add this to my saved trials
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared With Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Advanced Non-small Cell Lung Cancer.
Status: Enrolling
Updated:  4/9/2018
Northwest Medical Specialties
mi
from
Tacoma, WA
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared With Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Advanced Non-small Cell Lung Cancer.
Status: Enrolling
Updated: 4/9/2018
Northwest Medical Specialties
mi
from
Tacoma, WA
Click here to add this to my saved trials
Concordance of Inivata Liquid Biopsy With Standard Tissue Biopsy
An Observational Multicenter Study to Evaluate the Performance and Utility of Inivata Liquid Biopsy Analysis Compared With Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Lung Cancer
Status: Enrolling
Updated:  4/9/2018
Mercy Hospital Cancer Center/Clinical Research
mi
from
Fort Smith, AR
Concordance of Inivata Liquid Biopsy With Standard Tissue Biopsy
An Observational Multicenter Study to Evaluate the Performance and Utility of Inivata Liquid Biopsy Analysis Compared With Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Lung Cancer
Status: Enrolling
Updated: 4/9/2018
Mercy Hospital Cancer Center/Clinical Research
mi
from
Fort Smith, AR
Click here to add this to my saved trials
Concordance of Inivata Liquid Biopsy With Standard Tissue Biopsy
An Observational Multicenter Study to Evaluate the Performance and Utility of Inivata Liquid Biopsy Analysis Compared With Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Lung Cancer
Status: Enrolling
Updated:  4/9/2018
Mercy Cancer Center
mi
from
Joplin, MO
Concordance of Inivata Liquid Biopsy With Standard Tissue Biopsy
An Observational Multicenter Study to Evaluate the Performance and Utility of Inivata Liquid Biopsy Analysis Compared With Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Lung Cancer
Status: Enrolling
Updated: 4/9/2018
Mercy Cancer Center
mi
from
Joplin, MO
Click here to add this to my saved trials
Concordance of Inivata Liquid Biopsy With Standard Tissue Biopsy
An Observational Multicenter Study to Evaluate the Performance and Utility of Inivata Liquid Biopsy Analysis Compared With Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Lung Cancer
Status: Enrolling
Updated:  4/9/2018
Mercy Clinic
mi
from
Springfield, MO
Concordance of Inivata Liquid Biopsy With Standard Tissue Biopsy
An Observational Multicenter Study to Evaluate the Performance and Utility of Inivata Liquid Biopsy Analysis Compared With Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Lung Cancer
Status: Enrolling
Updated: 4/9/2018
Mercy Clinic
mi
from
Springfield, MO
Click here to add this to my saved trials
Concordance of Inivata Liquid Biopsy With Standard Tissue Biopsy
An Observational Multicenter Study to Evaluate the Performance and Utility of Inivata Liquid Biopsy Analysis Compared With Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Lung Cancer
Status: Enrolling
Updated:  4/9/2018
Mercy Clinic Oncology and Hematology
mi
from
Oklahoma City, OK
Concordance of Inivata Liquid Biopsy With Standard Tissue Biopsy
An Observational Multicenter Study to Evaluate the Performance and Utility of Inivata Liquid Biopsy Analysis Compared With Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Lung Cancer
Status: Enrolling
Updated: 4/9/2018
Mercy Clinic Oncology and Hematology
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Concordance of Inivata Liquid Biopsy With Standard Tissue Biopsy
An Observational Multicenter Study to Evaluate the Performance and Utility of Inivata Liquid Biopsy Analysis Compared With Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Lung Cancer
Status: Enrolling
Updated:  4/9/2018
Lehigh Valley Health Networks
mi
from
Allentown, PA
Concordance of Inivata Liquid Biopsy With Standard Tissue Biopsy
An Observational Multicenter Study to Evaluate the Performance and Utility of Inivata Liquid Biopsy Analysis Compared With Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Lung Cancer
Status: Enrolling
Updated: 4/9/2018
Lehigh Valley Health Networks
mi
from
Allentown, PA
Click here to add this to my saved trials
Concordance of Inivata Liquid Biopsy With Standard Tissue Biopsy
An Observational Multicenter Study to Evaluate the Performance and Utility of Inivata Liquid Biopsy Analysis Compared With Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Lung Cancer
Status: Enrolling
Updated:  4/9/2018
Gibbs Cancer Center & Research Institute
mi
from
Spartanburg, SC
Concordance of Inivata Liquid Biopsy With Standard Tissue Biopsy
An Observational Multicenter Study to Evaluate the Performance and Utility of Inivata Liquid Biopsy Analysis Compared With Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Lung Cancer
Status: Enrolling
Updated: 4/9/2018
Gibbs Cancer Center & Research Institute
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Cabozantinib-S-Malate and Erlotinib Hydrochloride in Treating Patients With Previously Treated Metastatic Non-Small Cell Lung Cancer
Phase II Trial of XL184 (Cabozantinib) Plus Erlotinib in Patients With Advanced EGFR-Mutant Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) Therapy
Status: Enrolling
Updated:  4/10/2018
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
Cabozantinib-S-Malate and Erlotinib Hydrochloride in Treating Patients With Previously Treated Metastatic Non-Small Cell Lung Cancer
Phase II Trial of XL184 (Cabozantinib) Plus Erlotinib in Patients With Advanced EGFR-Mutant Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) Therapy
Status: Enrolling
Updated: 4/10/2018
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Cabozantinib-S-Malate and Erlotinib Hydrochloride in Treating Patients With Previously Treated Metastatic Non-Small Cell Lung Cancer
Phase II Trial of XL184 (Cabozantinib) Plus Erlotinib in Patients With Advanced EGFR-Mutant Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) Therapy
Status: Enrolling
Updated:  4/10/2018
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Cabozantinib-S-Malate and Erlotinib Hydrochloride in Treating Patients With Previously Treated Metastatic Non-Small Cell Lung Cancer
Phase II Trial of XL184 (Cabozantinib) Plus Erlotinib in Patients With Advanced EGFR-Mutant Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) Therapy
Status: Enrolling
Updated: 4/10/2018
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Cabozantinib-S-Malate and Erlotinib Hydrochloride in Treating Patients With Previously Treated Metastatic Non-Small Cell Lung Cancer
Phase II Trial of XL184 (Cabozantinib) Plus Erlotinib in Patients With Advanced EGFR-Mutant Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) Therapy
Status: Enrolling
Updated:  4/10/2018
University of California-Davis Comprehensive Cancer Ctr
mi
from
Sacramento, CA
Cabozantinib-S-Malate and Erlotinib Hydrochloride in Treating Patients With Previously Treated Metastatic Non-Small Cell Lung Cancer
Phase II Trial of XL184 (Cabozantinib) Plus Erlotinib in Patients With Advanced EGFR-Mutant Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) Therapy
Status: Enrolling
Updated: 4/10/2018
University of California-Davis Comprehensive Cancer Ctr
mi
from
Sacramento, CA
Click here to add this to my saved trials
Cabozantinib-S-Malate and Erlotinib Hydrochloride in Treating Patients With Previously Treated Metastatic Non-Small Cell Lung Cancer
Phase II Trial of XL184 (Cabozantinib) Plus Erlotinib in Patients With Advanced EGFR-Mutant Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) Therapy
Status: Enrolling
Updated:  4/10/2018
City of Hope South Pasadena
mi
from
South Pasadena, CA
Cabozantinib-S-Malate and Erlotinib Hydrochloride in Treating Patients With Previously Treated Metastatic Non-Small Cell Lung Cancer
Phase II Trial of XL184 (Cabozantinib) Plus Erlotinib in Patients With Advanced EGFR-Mutant Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) Therapy
Status: Enrolling
Updated: 4/10/2018
City of Hope South Pasadena
mi
from
South Pasadena, CA
Click here to add this to my saved trials
Cabozantinib-S-Malate and Erlotinib Hydrochloride in Treating Patients With Previously Treated Metastatic Non-Small Cell Lung Cancer
Phase II Trial of XL184 (Cabozantinib) Plus Erlotinib in Patients With Advanced EGFR-Mutant Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) Therapy
Status: Enrolling
Updated:  4/10/2018
Wayne State University/Karmanos Cancer Institute
mi
from
Detroit, MI
Cabozantinib-S-Malate and Erlotinib Hydrochloride in Treating Patients With Previously Treated Metastatic Non-Small Cell Lung Cancer
Phase II Trial of XL184 (Cabozantinib) Plus Erlotinib in Patients With Advanced EGFR-Mutant Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) Therapy
Status: Enrolling
Updated: 4/10/2018
Wayne State University/Karmanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
Cabozantinib-S-Malate and Erlotinib Hydrochloride in Treating Patients With Previously Treated Metastatic Non-Small Cell Lung Cancer
Phase II Trial of XL184 (Cabozantinib) Plus Erlotinib in Patients With Advanced EGFR-Mutant Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) Therapy
Status: Enrolling
Updated:  4/10/2018
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Cabozantinib-S-Malate and Erlotinib Hydrochloride in Treating Patients With Previously Treated Metastatic Non-Small Cell Lung Cancer
Phase II Trial of XL184 (Cabozantinib) Plus Erlotinib in Patients With Advanced EGFR-Mutant Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) Therapy
Status: Enrolling
Updated: 4/10/2018
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Cabozantinib-S-Malate and Erlotinib Hydrochloride in Treating Patients With Previously Treated Metastatic Non-Small Cell Lung Cancer
Phase II Trial of XL184 (Cabozantinib) Plus Erlotinib in Patients With Advanced EGFR-Mutant Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) Therapy
Status: Enrolling
Updated:  4/10/2018
University of Pittsburgh Cancer Institute (UPCI)
mi
from
Pittsburgh, PA
Cabozantinib-S-Malate and Erlotinib Hydrochloride in Treating Patients With Previously Treated Metastatic Non-Small Cell Lung Cancer
Phase II Trial of XL184 (Cabozantinib) Plus Erlotinib in Patients With Advanced EGFR-Mutant Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) Therapy
Status: Enrolling
Updated: 4/10/2018
University of Pittsburgh Cancer Institute (UPCI)
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Comprehensive Genomic Analysis in Tissue and Blood Samples From Young Patients With Lung Cancer
Genomics of Young Lung Cancer Study
Status: Enrolling
Updated:  4/12/2018
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Comprehensive Genomic Analysis in Tissue and Blood Samples From Young Patients With Lung Cancer
Genomics of Young Lung Cancer Study
Status: Enrolling
Updated: 4/12/2018
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Comprehensive Genomic Analysis in Tissue and Blood Samples From Young Patients With Lung Cancer
Genomics of Young Lung Cancer Study
Status: Enrolling
Updated:  4/12/2018
Dana-Farber Cancer Institute
mi
from
Boston, MA
Comprehensive Genomic Analysis in Tissue and Blood Samples From Young Patients With Lung Cancer
Genomics of Young Lung Cancer Study
Status: Enrolling
Updated: 4/12/2018
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Broncho-Adventitial Delivery of Paclitaxel to Extend Airway Patency in Malignant Airway Obstruction Patients
Broncho-Adventitial Delivery of Paclitaxel to Extend Airway Patency in Malignant Airway Obstruction Patients
Status: Enrolling
Updated:  4/18/2018
Johns Hopkins University
mi
from
Baltimore, MD
Broncho-Adventitial Delivery of Paclitaxel to Extend Airway Patency in Malignant Airway Obstruction Patients
Broncho-Adventitial Delivery of Paclitaxel to Extend Airway Patency in Malignant Airway Obstruction Patients
Status: Enrolling
Updated: 4/18/2018
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Broncho-Adventitial Delivery of Paclitaxel to Extend Airway Patency in Malignant Airway Obstruction Patients
Broncho-Adventitial Delivery of Paclitaxel to Extend Airway Patency in Malignant Airway Obstruction Patients
Status: Enrolling
Updated:  4/18/2018
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Broncho-Adventitial Delivery of Paclitaxel to Extend Airway Patency in Malignant Airway Obstruction Patients
Broncho-Adventitial Delivery of Paclitaxel to Extend Airway Patency in Malignant Airway Obstruction Patients
Status: Enrolling
Updated: 4/18/2018
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Broncho-Adventitial Delivery of Paclitaxel to Extend Airway Patency in Malignant Airway Obstruction Patients
Broncho-Adventitial Delivery of Paclitaxel to Extend Airway Patency in Malignant Airway Obstruction Patients
Status: Enrolling
Updated:  4/18/2018
Duke University
mi
from
Raleigh, NC
Broncho-Adventitial Delivery of Paclitaxel to Extend Airway Patency in Malignant Airway Obstruction Patients
Broncho-Adventitial Delivery of Paclitaxel to Extend Airway Patency in Malignant Airway Obstruction Patients
Status: Enrolling
Updated: 4/18/2018
Duke University
mi
from
Raleigh, NC
Click here to add this to my saved trials
Effects of Essential Amino Acid Intake on Net Protein Synthesis in Weight-losing Non-small Cell Lung Cancer Patients
Effects of Essential Amino Acid Intake on Net Protein Synthesis in Weight-losing Non-small Cell Lung Cancer Patients
Status: Enrolling
Updated:  4/24/2018
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Effects of Essential Amino Acid Intake on Net Protein Synthesis in Weight-losing Non-small Cell Lung Cancer Patients
Effects of Essential Amino Acid Intake on Net Protein Synthesis in Weight-losing Non-small Cell Lung Cancer Patients
Status: Enrolling
Updated: 4/24/2018
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials
Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
A Phase I Trial of CCL21 Gene Modified Dendritic Cells In Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  4/26/2018
Jonsson Comprehensive Cancer Center at UCLA
mi
from
Los Angeles, CA
Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
A Phase I Trial of CCL21 Gene Modified Dendritic Cells In Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 4/26/2018
Jonsson Comprehensive Cancer Center at UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
A Phase I Trial of CCL21 Gene Modified Dendritic Cells In Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  4/26/2018
VA Greater Los Angeles
mi
from
Los Angeles, CA
Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
A Phase I Trial of CCL21 Gene Modified Dendritic Cells In Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 4/26/2018
VA Greater Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Stereotactic Body Radiotherapy and Radiofrequency Ablation for Lung Tumors Near Central Airways
Phase II Study Evaluating Safety and Efficacy of Stereotactic Body Radiotherapy and Radiofrequency Ablation for Medically Inoperable and Recurrent Lung Tumors Near Central Airways
Status: Enrolling
Updated:  4/26/2018
UCLA Jonsson Comprehensive Cancer Center
mi
from
Los Angeles, CA
Stereotactic Body Radiotherapy and Radiofrequency Ablation for Lung Tumors Near Central Airways
Phase II Study Evaluating Safety and Efficacy of Stereotactic Body Radiotherapy and Radiofrequency Ablation for Medically Inoperable and Recurrent Lung Tumors Near Central Airways
Status: Enrolling
Updated: 4/26/2018
UCLA Jonsson Comprehensive Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Pemetrexed Disodium and Hsp90 Inhibitor AUY922 in Treating Patients With Previously Treated Stage IV Non-Small Cell Lung Cancer
A Phase IB Dose-Escalation Study of Pemetrexed and AUY922 in Previously-Treated Patients With Metastatic Non-Squamous, Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  4/26/2018
Jonsson Comprehensive Cancer Center
mi
from
Los Angeles, CA
Pemetrexed Disodium and Hsp90 Inhibitor AUY922 in Treating Patients With Previously Treated Stage IV Non-Small Cell Lung Cancer
A Phase IB Dose-Escalation Study of Pemetrexed and AUY922 in Previously-Treated Patients With Metastatic Non-Squamous, Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 4/26/2018
Jonsson Comprehensive Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer
A Phase l/ll, Open Label, Dose-escalation Study of Varlilumab (CDX-1127) in Combination With Atezolizumab (MPDL3280A, Anti-PD-L1) in Patients With Advanced Cancer
Status: Enrolling
Updated:  4/26/2018
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer
A Phase l/ll, Open Label, Dose-escalation Study of Varlilumab (CDX-1127) in Combination With Atezolizumab (MPDL3280A, Anti-PD-L1) in Patients With Advanced Cancer
Status: Enrolling
Updated: 4/26/2018
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer
A Phase l/ll, Open Label, Dose-escalation Study of Varlilumab (CDX-1127) in Combination With Atezolizumab (MPDL3280A, Anti-PD-L1) in Patients With Advanced Cancer
Status: Enrolling
Updated:  4/26/2018
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer
A Phase l/ll, Open Label, Dose-escalation Study of Varlilumab (CDX-1127) in Combination With Atezolizumab (MPDL3280A, Anti-PD-L1) in Patients With Advanced Cancer
Status: Enrolling
Updated: 4/26/2018
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer
A Phase l/ll, Open Label, Dose-escalation Study of Varlilumab (CDX-1127) in Combination With Atezolizumab (MPDL3280A, Anti-PD-L1) in Patients With Advanced Cancer
Status: Enrolling
Updated:  4/26/2018
Duke Univ Med Ctr
mi
from
Durham, NC
A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer
A Phase l/ll, Open Label, Dose-escalation Study of Varlilumab (CDX-1127) in Combination With Atezolizumab (MPDL3280A, Anti-PD-L1) in Patients With Advanced Cancer
Status: Enrolling
Updated: 4/26/2018
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer
A Phase l/ll, Open Label, Dose-escalation Study of Varlilumab (CDX-1127) in Combination With Atezolizumab (MPDL3280A, Anti-PD-L1) in Patients With Advanced Cancer
Status: Enrolling
Updated:  4/26/2018
University of California at San Francisco
mi
from
San Francisco, CA
A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer
A Phase l/ll, Open Label, Dose-escalation Study of Varlilumab (CDX-1127) in Combination With Atezolizumab (MPDL3280A, Anti-PD-L1) in Patients With Advanced Cancer
Status: Enrolling
Updated: 4/26/2018
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
An Immuno-Therapy Study of Experimental Medication BMS-986205 Given With Nivolumab With or Without Chemotherapy Compared to Chemotherapy in Participants With Previously Untreated Stage IV or Recurrent Non-Small Cell Lung Cancer
A Phase 3 Open Label, Randomized Study of BMS-986205 Combined With Nivolumab With or Without Chemotherapy Versus Chemotherapy in Participants With Previously Untreated Stage IV or Recurrent Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  4/26/2018
Local Institution
mi
from
San Diego, CA
An Immuno-Therapy Study of Experimental Medication BMS-986205 Given With Nivolumab With or Without Chemotherapy Compared to Chemotherapy in Participants With Previously Untreated Stage IV or Recurrent Non-Small Cell Lung Cancer
A Phase 3 Open Label, Randomized Study of BMS-986205 Combined With Nivolumab With or Without Chemotherapy Versus Chemotherapy in Participants With Previously Untreated Stage IV or Recurrent Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 4/26/2018
Local Institution
mi
from
San Diego, CA
Click here to add this to my saved trials
An Immuno-Therapy Study of Experimental Medication BMS-986205 Given With Nivolumab With or Without Chemotherapy Compared to Chemotherapy in Participants With Previously Untreated Stage IV or Recurrent Non-Small Cell Lung Cancer
A Phase 3 Open Label, Randomized Study of BMS-986205 Combined With Nivolumab With or Without Chemotherapy Versus Chemotherapy in Participants With Previously Untreated Stage IV or Recurrent Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  4/26/2018
Local Institution
mi
from
Jacksonville, FL
An Immuno-Therapy Study of Experimental Medication BMS-986205 Given With Nivolumab With or Without Chemotherapy Compared to Chemotherapy in Participants With Previously Untreated Stage IV or Recurrent Non-Small Cell Lung Cancer
A Phase 3 Open Label, Randomized Study of BMS-986205 Combined With Nivolumab With or Without Chemotherapy Versus Chemotherapy in Participants With Previously Untreated Stage IV or Recurrent Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 4/26/2018
Local Institution
mi
from
Jacksonville, FL
Click here to add this to my saved trials